Special Issue "Neuroactive Compounds"

Quicklinks

A special issue of Molecules (ISSN 1420-3049).

Deadline for manuscript submissions: closed (31 December 2010)

Special Issue Editor

Guest Editor
Dr. Maurice Tangui
INSERM U. 710, University of Montpellier 2, 34095 Montpellier cedex 5, France
Website: http://www.mmdn.univ-montp2.fr/equipe2.html
E-Mail: tangui.maurice@univ-montp2.fr

Special Issue Information

Dear Colleagues,

Research in Neuroscience has never been so active, taking benefits from recent developments in functional imaging, molecular biology and transgenesis, or improvements in animals’ cognitive behavioral analyses. Paradoxically, validation of new therapeutic strategies and marketing of really innovative medicine against pathologies with major social issues like Alzheimer’s disease and related neurodegenerative disorders, ischemic insults, depression, or schizophrenia mark time and do not find way out in a near future. Drug development pipelines of pharmaceutical companies remain alarmingly empty.
This combined Special Issue of Molecules and Pharmaceuticals, on Neuroactive Compounds, will offer an unique forum to present the chemistry, pharmacology and therapeutic opportunities offered by new and innovative molecular series in all areas of neuropharmacology and neuroscience. I strongly encourage authors to submit papers for this special issue, within the scope of Molecules and Pharmaceuticals, and I hope that the fields covered will allow to rise our hopes in seeing soon the validation of breakthrough treatments in central pathologies of major concern.

Dr. Tangui Maurice
Guest Editor

Related Special Issues

Keywords

  • psychoactive drugs
  • neuroprotective agents
  • antidepressant
  • anxiolytics
  • anti-stress drugs
  • brain imaging tools
  • brain penetration
  • blood-brain barrier agents

Published Papers (6 papers)

by , ,  and
Molecules 2011, 16(5), 4045-4058; doi:10.3390/molecules16054045
Received: 28 February 2011; in revised form: 26 April 2011 / Accepted: 16 May 2011 / Published: 17 May 2011
Show/Hide Abstract | PDF Full-text (539 KB)

by , ,  and
Molecules 2011, 16(3), 2726-2742; doi:10.3390/molecules16032726
Received: 13 December 2010; in revised form: 18 March 2011 / Accepted: 22 March 2011 / Published: 23 March 2011
Show/Hide Abstract | Cited by 8 | PDF Full-text (216 KB)

by
Molecules 2011, 16(3), 2233-2252; doi:10.3390/molecules16032233
Received: 4 January 2011; in revised form: 10 February 2011 / Accepted: 4 March 2011 / Published: 7 March 2011
Show/Hide Abstract | Cited by 20 | PDF Full-text (280 KB)
abstract graphic

by  and
Molecules 2011, 16(3), 2097-2106; doi:10.3390/molecules16032097
Received: 6 January 2011; in revised form: 8 February 2011 / Accepted: 28 February 2011 / Published: 2 March 2011
Show/Hide Abstract | Cited by 22 | PDF Full-text (122 KB)

by  and
Molecules 2011, 16(2), 1471-1485; doi:10.3390/molecules16021471
Received: 22 December 2010; in revised form: 21 January 2011 / Accepted: 26 January 2011 / Published: 10 February 2011
Show/Hide Abstract | Cited by 52 | PDF Full-text (140 KB)

by ,  and
Molecules 2010, 15(8), 5581-5594; doi:10.3390/molecules15085581
Received: 27 July 2010; in revised form: 10 August 2010 / Accepted: 12 August 2010 / Published: 13 August 2010
Show/Hide Abstract | Cited by 12 | PDF Full-text (166 KB)
abstract graphic

Last update: 4 March 2014

Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert